<- Go Home
NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Market Cap
$128.5M
Volume
1.9M
Cash and Equivalents
$2.3M
EBITDA
-$5.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.5M
Profit Margin
63.32%
52 Week High
$4.44
52 Week Low
$0.46
Dividend
N/A
Price / Book Value
-2.29
Price / Earnings
-1.01
Price / Tangible Book Value
-2.29
Enterprise Value
$131.5M
Enterprise Value / EBITDA
-27.80
Operating Income
-$5.1M
Return on Equity
516.26%
Return on Assets
-86.98
Cash and Short Term Investments
$2.3M
Debt
$970.0K
Equity
$1.6M
Revenue
$10.3M
Unlevered FCF
-$2.7M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium